Clinical trial
Mutation-specific Therapy for the Long QT Syndrome
NCT04581408 is registered in ClinicalTrials.gov with Istituto Auxologico Italiano as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mutation-specific Therapy for the Long QT Syndrome
- Lead sponsor
- Istituto Auxologico Italiano
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 15, 2021
- Completion date
- April 15, 2025
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.